1,3,4-Trisubstituted pyrrolidine CCR5 receptor antagonists. Part 1: discovery of the pyrrolidine scaffold and determination of its stereochemical requirements

This publication has 20 references indexed in Scilit:

• Antagonists of the human CCR5 receptor as anti-HIV-1 agents. Part 1: Discovery and initial structure–activity relationships for 1-amino-2-phenyl-4-(piperidin-1-yl)butanes
  Bioorganic & Medicinal Chemistry Letters, 2001
• Therapeutic potential of blocking HIV entry into cells: focus on membrane fusion inhibitors
  Expert Opinion on Investigational Drugs, 1999
• A small-molecule, nonpeptide CCR5 antagonist with highly potent and selective anti-HIV-1 activity
  Proceedings of the National Academy of Sciences, 1999
• Changing patterns of mortality across Europe in patients infected with HIV-1
  The Lancet, 1998
• HIV-Protease Inhibitors
  New England Journal of Medicine, 1998
• Declining Morbidity and Mortality among Patients with Advanced Human Immunodeficiency Virus Infection
  New England Journal of Medicine, 1998
• Resistance to HIV-1 infection in Caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene
  Nature, 1996
• Homozygous Defect in HIV-1 Coreceptor Accounts for Resistance of Some Multiply-Exposed Individuals to HIV-1 Infection
  Cell, 1996
• HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5
  Nature, 1996
• Identification of a major co-receptor for primary isolates of HIV-1
  Nature, 1996